Abbvie Inc Drug Patent Portfolio

Abbvie Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Abbvie Inc News

What Impact Will Skyrizi and Rinvoq Have on AbbVie's Immunology Sales in Q1? - TradingView

06 Apr, 2026

Comparing High Yield and Sustainable Growth: The Reasons AbbVie's Dividend Outshines Pfizer's Even with a Smaller Distribution

06 Apr, 2026

Exchange Traded Concepts Increases Its Investment in AbbVie by 150% - North Chicago Today

28 Mar, 2026

AbbVie: A Steady Provider of Dividend Earnings | Intellectia.AI

27 Mar, 2026

See More